ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CIPH Ciphergen Biosystems (MM)

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Ciphergen Biosystems (MM) NASDAQ:CIPH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Ciphergen to Announce Q1 2007 Financial Results and Host Conference Call on Wednesday, May 16, 2007

14/05/2007 3:30pm

PR Newswire (US)


Ciphergen Biosystems (NASDAQ:CIPH)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Ciphergen Biosystems Charts.
FREMONT, Calif., May 14 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH), will announce first quarter 2007 financial results on Wednesday, May 16, 2007 before market open. A conference call and webcast will be held on Wednesday, May 16, 2007 at 11 a.m. Eastern Time to discuss these results and provide an update on business developments. To access the live conference call via phone, dial (877) 325-7371 from the United States and Canada or (706) 634-0768 internationally. The conference ID is 21338536. Please dial-in approximately ten minutes prior to the start of the call. Additionally, you may access the live and subsequently archived webcast of the conference call from the Investor Relations section of the Company's website at http://www.ciphergen.com/. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. A telephone replay will be available beginning approximately two hours after the call through May 23, 2007 and may be accessed by dialing (800) 633-8284 from the United States and Canada or +1(402) 977-9140 internationally. The replay passcode is 21338536. An archived replay of the call will be available until the next quarterly call. About Ciphergen Ciphergen Biosystems, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Ciphergen, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California, more information about Ciphergen can be found on the Web at http://www.ciphergen.com/. If you are unable to participate during the live webcast, the call will be archived on the Web site http://www.ciphergen.com/ DATASOURCE: Ciphergen Biosystems, Inc. CONTACT: Sue Carruthers, Investor Relations of Ciphergen Biosystems, Inc., +1-510-505-2297 Web site: http://www.ciphergen.com/

Copyright

1 Year Ciphergen Biosystems Chart

1 Year Ciphergen Biosystems Chart

1 Month Ciphergen Biosystems Chart

1 Month Ciphergen Biosystems Chart